Jan 27 2010
Today Labcyte introduced two pre-calibrated liquid class packages for
use with its award-winning Echo® acoustic dispensers and POD™
810 plate assemblers, which move liquids with sound. This expanded
capability will allow its high throughput screening customers to not
only transfer compounds in DMSO, but enables the transfer of a wide
range of liquids necessary to assemble miniaturized assays for
biochemical and cell-based screening. In addition the Echo platform can
now address a wide range of growing applications in Genomics and
Proteomics such as siRNA screening, real-time PCR genotyping, and
protein-based arrays.
“Our users can now run a wide range of
applications where they need to transfer compounds in DMSO, or aqueous
solutions that contain DNA, RNA or proteins, surfactants, and buffers.
All of this is done without the use of disposable tips leading to better
results and lower costs.”
“Labcyte has revolutionized liquid handling with multiple systems in all
of the top 10 pharmaceutical companies,” said Mark Fischer-Colbrie,
Chief Executive Officer and President of Labcyte. “We are now positioned
to offer the same guaranteed level of precision and accuracy to a brand
new set of customers who are looking to miniaturize their assays while
getting better results and cost savings due to the Echo platform’s
‘touchless’ dispensing capability.”
“The Echo Screening Package and the Echo Omics Package allow customers
to change applications, on the fly, without the need for custom
calibrations,” said Stephen Bates, Sr. Vice President of Sales,
Marketing and Support. “Our users can now run a wide range of
applications where they need to transfer compounds in DMSO, or aqueous
solutions that contain DNA, RNA or proteins, surfactants, and buffers.
All of this is done without the use of disposable tips leading to better
results and lower costs.”
Labcyte also introduced a 1536-well source plate which meets user
requests for lower dead volume and increased working volume. The new
1536LDV plate cuts dead volume in half, increases the working volume by
12.5% and provides greater throughput compared to other 1536-well source
plates.
Proimmune Ltd introduces Prove® SL Self-Loading MHC Class I Monomers to improve T cell research flexibility